Co-infection with human CMV genetic variants in transplant recipients and its impact on anti-viral T cell immunity
نویسندگان
چکیده
3 Corey Smith, Rebekah M. Brennan, Siok-Keen Tey , Mark J. Smyth , Scott. R. Burrows, 4 John J. Miles, Geoffrey R. Hill 2 and Rajiv Khanna 5 6 QIMR Berghofer Medical Research Institute, QIMR Berghofer Centre for Immunotherapy 7 and Vaccine Development, Brisbane 4029 QLD Australia 8 Bone Marrow Transplant Unit, Royal Brisbane Hospital, Brisbane, 4006 QLD Australia 9 Institute of Infection and Immunity, Cardiff University, School of Medicine, Heath Park, 10 Cardiff CF14 4XN, UK 11 12 Running Title: CMV genetic variation in HSCT recipients 13 14 * Corresponding author 15 Address for correspondence and reprint requests 16 Dr Corey Smith, QIMR Berghofer Medical Research Institute, Tumour Immunology 17 Laboratory, Department of Immunology, 300 Herston Rd, Brisbane, Australia 4006. Tel: 6118 7-3845 3802; Fax: 61-7-38453510; Email: [email protected]. 19 20 21 22 23 JVI Accepted Manuscript Posted Online 8 June 2016 J. Virol. doi:10.1128/JVI.00297-16 Copyright © 2016, American Society for Microbiology. All Rights Reserved.
منابع مشابه
Incidence of ganciclovir resistance in CMV-positive renal transplant recipients and its association with UL97 gene mutations
Human cytomegalovirus (CMV) remains the most common infection affecting organ transplant recipients. Despite advances in the prophylaxis and acute treatment of CMV, it remains an important pathogen affecting the short- and long-term clinical outcome of solid organ transplant recipient. The emergence of CMV resistance in a patient reduces the clinical efficacy of antiviral therapy, complicates t...
متن کاملIncidence of ganciclovir resistance in CMV-positive renal transplant recipients and its association with UL97 gene mutations
Human cytomegalovirus (CMV) remains the most common infection affecting organ transplant recipients. Despite advances in the prophylaxis and acute treatment of CMV, it remains an important pathogen affecting the short- and long-term clinical outcome of solid organ transplant recipient. The emergence of CMV resistance in a patient reduces the clinical efficacy of antiviral therapy, complicates t...
متن کاملMolecular Imprint of Exposure to Naturally Occurring Genetic Variants of Human Cytomegalovirus on the T cell Repertoire
Exposure to naturally occurring variants of herpesviruses in clinical settings can have a dramatic impact on anti-viral immunity. Here we have evaluated the molecular imprint of variant peptide-MHC complexes on the T-cell repertoire during human cytomegalovirus (CMV) infection and demonstrate that primary co-infection with genetic variants of CMV was coincident with development of strain-specif...
متن کاملAntiviral agents for preventing cytomegalovirus infection in pediatric renal transplant recipients: A systematic review
Background and Objective: Cytomegalovirus (CMV) infections are associated with severe morbidity and mortality in patients, especially pediatric renal transplantation patients. The use of immunosuppressive agents places these patients at the risk of viral infections. As cytomegalovirus infection influences the graft outcome, adopting useful strategies for limiting this virus after transplantatio...
متن کاملAssessment of the T-SPOT.CMV interferon-γ release assay in renal transplant recipients: A single center cohort study
BACKGROUND The measurement of CMV specific cellular immunity in organ transplant recipients could contribute additional acuity to serology based, CMV infection risk stratification, facilitating optimisation of immunosuppression and anti-viral prophylaxis. METHODS A pilot study of renal transplant recipient (RTR's) responses in the T-SPOT.CMV ELISPOT based assay. 108 RTR's were recruited 3 mon...
متن کامل